Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues |
| Ionis Core | | | | | 641.9 | 525.2 | | 286.4 |
| Akcea Therapeutics | | | | | 64.9 | 43.4 | | |
| |
| EBIT |
| Ionis Core | | | | | 261.7 | 151.4 | 63.2 | -23.1 |
| Akcea Therapeutics | | | | | -230.8 | -120.5 | -83.5 | -52.7 |
| |
| Mix |
| Ionis Core | | | | | 107.0% | 102.1% | | 100.9% |
| Akcea Therapeutics | | | | | 10.8% | 8.4% | | |
| |
| Growth |
| Ionis Core | | | | | 22.2% | | | 33.7% |
| Akcea Therapeutics | | | | | 49.5% | | | |
|